In vivo, at low concentrations (<_1 ug/ml), the antibiotic lipiarmycin specifically inhibits RNA synthesis in Bacillus subtilis. At a much higher concentration (100ug/ml), syntheses of other macromolecules such as DNA and protein also appear to be suppressed.
In vitro, the antibiotic causes 50% inhibition of DNA-dependent RNApolymerase from B. subtilis at a concentration of 0.6 ug/ml and of that from E. coli at 5~8 ug/ml. The activity of Escherichia coli DNA-polymerase I is inhibited 50% at 55~65 pg/ml.
Lipiarmycin prevents ribonucleoside triphosphate polymerization only if added prior to the association between RNA-polymerase and DNA, and does not affect the elongation rate of RNA chains at concentrations up to 100 ug/ml. 
In Vivo Effects on Macromolecule Synthesis
The addition of lipiarmycin at 1 pg/ml to an exponentially growing culture of B. subtilis results in a rapid cessation of cellular growth, concomitant with a suppression of uracil incorporation. After a short lag period, protein synthesis is also arrested, whereas DNA synthesis remains virtually unaffected for at least thirty minutes (Fig. 1 ). This pattern of inhibition is typical of compounds known to inhibit RNA synthesis.
With a concentration of 100 pg/ml, DNA synthesis is also depressed within a few minutes after addition of antibiotic to the growing culture, while protein synthesis stops almost immediately. In order to identify the subcellular target of lipiarmycin, the antibiotic was tested on the activities of purified RNA-and DNA-polymerises. The reaction mixture contained 40 mM TrisHCl pH 7.9. 0.15 M KCl 0.1 mM dithiothreitol, 10 mM MgCl2. 4 mM MnCl2, 0.4 mM Na phosphate buffer pH 7.4; 0.16 mm UTP, CTP, GTP and 3H-ATP (12 .5 mCi/mM), 150 pg/ml of calf thymus DNA, or T4-DNA, or poly dA-T, and 5 units/ ml of E. coli RNA polymerase in a final volume of 0.1 ml. In the assay of poly dA-T primed polyribonucleotide synthesis, CTP and GTP were omitted.
Assay tubes were incubated at 36°C for 15 minutes. Assay tubes were incubated at 36°C for 20 minutes and contained 40 mM Tris • HC1 pH 7.9, 10 mm MgCl2, 0.1 mm dithiothreitol, 0.1 mM EDTA, 1.28 mM ATP and GTP, 0.13 mM CTP and 14C-UTP (3 .5 mCi/mM), 100 pg/ml of calf thymus.
DNA, E. coli RNA polymerase (10 pg of protein) or RNA polymerase from B. subtilis (5 pg of protein) and lipiarmycin in a final volume of 0.1 ml. Without the antibiotic E. coli RNA-polymerase incorporated 1.78 mu moles of UTP, the polymerase from B. subtilis 0.50mu moles of UTP. and B. subtilis, lipiarmycin is about 8 times more effective against the B. subtilis enzyme, 0.6 pg/ml giving 50% inhibition (Fig. 3 ).
Enzyme-DNA complex.
DNA-dependent DNA-polymerase
Since high concentrations of lipiarmycin inhibit in vivo DNA synthesis, we have investigated its action on purified DNA-polymerase I from E. coli. As shown in Fig. 6 , inhibition is concentration-dependent. 50% inhibition was seen at 55 pg/ml with poly dA-T as template, and at 65 fig/ml with calf thymus DNA as template. Thus, DNA-polymerase is 10 times less sensitive to the drug than is RNA-polymerase, when a natural template is used, but equally sensitive when the polymerization is primed with poly dA-T.
The time course of the effect on DNA-polymerase differs from that observed with DNApolymerase. The drug causes immediate inhibition when added either at zero time or 5 minutes after the beginning of the polymerization reaction (Fig. 7) .
Lack of Effect on Protein Synthesis
At concentrations up to 100 pg/ml, no effect of the antibiotic was observed in a cell-free peptide synthetizing system, programmed with either poly-U or endogenous m-RNA. In this assay system, uncharged t-RNA is used. Therefore, it can be deduced that lipiarmycin does not interfere with aminoacylation of t-RNA. The in viro effect on protein synthesis, i. e., the The reaction mixture had the same composition as in Fig. 2 except that calf thymus DNA (150'g/ml) was used at template.
The antibiotics were added either at zero time or after 5 minutes, as indicated by the arrow. Lipiarmycin and streptolydigin were 100 ,ug/ml, rifampicin was 1 Fig/ml .
Incubation was at 30°C, at intervals aliquots of 0.1 ml were withdrawn and the incorporated radioactivity determined. The experimental conditions were the same as described in Fig. 4 rapid arrest of amino acid incorporation observed at high concentrations of antibiotic, might therefore be due to some general damage to the cell, rather than to a specific inhibition.
Attempts to show Interaction of Lipiarmycin with DNA Lipiarmycin at a concentration of 100 leg/ml does not affect the rate of DNA hydrolysis catalyzed by pancreatic deoxyribonuclease.
At 50 leg/ml, lipiarmycin does not alter the melting point or the renaturation profile of B. subtilis DNA. Finally, the absorption spectrum of the drug was not modified on incubation with DNA.
Discussion
The data presented indicate that the antibiotic lipiarmycin specifically inhibits nucleic acid synthesis both in vim and in vitro. In both circumstances, however, RNA synthesis is more sensitive to the antibiotic than is DNA synthesis. Lipiarmycin has been reported recently to inhibit also RNA-polymerase from calf thymus nuclei although at a concentration 10 times higher than that needed to inhibit E. coli RNA-polymerase.7)
Lipiarmycin appears to impair the initiation of RNA chain synthesis in a highly specific manner.
The antibiotic prevents RNA synthesis in vitro completely only when it is added before the reaction initiates. Addition of the drug after the reaction has begun, results in a lag period before synthesis stops, since RNA chain completion continues for several minutes. the related streptovaricins,8) phenanthroline10) and, apparently, the acidic dyes, Congo Red,11,12) Galling12) and aurintricarboxylic acid.13) On the other hand, a preferential inhibition of RNA chain initiation has also been reported for drugs interacting with DNA, such as proflavine15) and distamycin,14)
so that alternative can not be excluded on this basis alone. However, attempts to show interaction of the antibiotic with DNA were unsuccessful, which would seem to favor the hypothesis that the inhibitor acts on the enzyme.
